Beta Drugs Ltd.

BSE: 535022	Sector: Health care
NSE: BETA	ISIN Code: INE351Y01019

BSE 05:30 | 01 Jan

Beta Drugs Ltd

NSE 00:00 | 07 May

208.45

9.90
(4.99%)

OPEN

208.40

HIGH

208.45

LOW

208.40

Add to Watchlist | Add to Portfolio

OPEN
PREVIOUS CLOSE
VOLUME
52-Week high	0.00
52-Week low	0.00
P/E
Mkt Cap.(Rs cr)	0
Buy Price
Buy Qty
Sell Price
Sell Qty

OPEN
CLOSE
VOLUME
52-Week high	0.00
52-Week low	0.00
P/E
Mkt Cap.(Rs cr)	0
Buy Price
Buy Qty
Sell Price
Sell Qty

Click here for interactive graph

Beta Drugs Ltd. (BETA) - News Sector

Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines

10.39 pm | 7 May 2021 | Business Standard

Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import
Amid supply crunch, private hospitals eyeing import of Covid-19 vaccines

10.39 pm | 7 May 2021 | Business Standard

Two major hospital groups, Apollo Hospitals and Fortis Healthcare, said they are open to exploring opportunities to import
India's pharma market rebounds in April, clocks 51.5% sales growth

10.06 pm | 7 May 2021 | Business Standard

Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth
India's pharma market rebounds in April, clocks 51.5% sales growth

10.06 pm | 7 May 2021 | Business Standard

Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth
India's pharma market rebounds in April, clocks 51.5% sales growth

10.06 pm | 7 May 2021 | Business Standard

Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth
Anupam Rasayan rallies 13% in 2 days after Plutus Wealth buys stake

12.32 pm | 6 May 2021 | Business Standard

On May 5, Plutus Wealth Management purchased 1 million shares, representing 1 per cent stake of Anupam Rasayan India, for Rs 64.75 crore
Lupin soars 8%, hits over three-year high on heavy volumes

11.33 am | 5 May 2021 | Business Standard

The stock surpassed its previous high of Rs 1,121.85 touched on September 2020 and was trading at the highest level since July 2017
Alembic Pharma falls 6% post March quarter results

10.04 am | 5 May 2021 | Business Standard

Alembic Pharma Q4FY21 operational performance was marginally below estimates, largely due to lower traction in US and Domestic Formulation (DF) sales
Hikal hits new high on signing 10-year deal with global pharma Co

9.36 am | 5 May 2021 | Business Standard

This contract entails the development and supply of a portfolio of niche APIs (Active Pharmaceutical Ingredient) over a period of 10 years
Nifty close below 14,416 would be bearish for short-term: Vinay Rajani

8.28 am | 5 May 2021 | Business Standard

Below 14,416, Nifty could slide towards next support of 14,150
Pricing pressure in US market to impact margins of pharma companies

11.48 pm | 4 May 2021 | Business Standard

Lack of new launches due to inspection delays, intensifying competition key headwinds
Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses

8.24 pm | 4 May 2021 | Business Standard

Net sales rise 6% to Rs 1,280 cr; API business expands by as much as 38%
Consolidation continues on D St; Sensex falls 465 pts; Nifty PSU Bank up 3%

4.20 pm | 4 May 2021 | Business Standard

Nearly 35 of the 50 constituents on the index ended the day in the red including Tata Consumer Products (down 4.3 per cent), Cipla, Reliance Industrie...
All you need to know about Commodity Channel Index in trading

8.34 am | 4 May 2021 | Business Standard

The basic philosophy of CCI is based on the assumption that commodities, stocks and bonds trade in a cycle with a peak and a trough arrived at on a pe...
This smallcap pharma stock has zoomed 101% in a month

12.52 pm | 3 May 2021 | Business Standard

On April 28, Morepen Group sealed $100 million (Rs 750 crore approx.) investment from Corinth Group of Switzerland
Laurus Labs shares advance 5% on strong growth outlook

11.50 am | 3 May 2021 | Business Standard

Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model
Natco Pharma gains 4% on emergency use approval for Covid-19 medicine

11.03 am | 3 May 2021 | Business Standard

The company has received Emergency Use approval for Baricitinib tablets, 1mg, 2mg and 4mg strengths from Central Drugs Standard Control Organization (...
Top trading ideas by Bharat Gala of Ventura Sec: Buy Nocil, Divi's Labs

8.58 am | 3 May 2021 | Business Standard

Recently, the stock of Divi's Labs has given a weekly range breakout, making a new high of 4133, supported by volumes
Amid weak showing by biosimilars and generics, downgrade pressure on Biocon

11.27 pm | 2 May 2021 | Business Standard

Analysts expect ramp-up in biosimilars to be gradual
Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw

10.28 pm | 30 Apr 2021 | Business Standard

The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step